AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimidale M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Allen Dale Biosciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimidale M 1mg/500mg Tablet SR

Diabetic patients using Glimidale M 1mg/500mg SR tablets, a dual-action antidiabetic medication, manage type 2 diabetes mellitus. This formulation combines two medications to regulate blood glucose. Administer this extended-release tablet with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; premature discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, Glimidale M is part of a comprehensive diabetes management plan incorporating diet, exercise, and weight control as recommended by your doctor. Commonly, hypoglycemia (low blood sugar) manifests as sweating, dizziness, headache, or tremors. Maintain regular mealtimes and carry a rapid-acting glucose source (e.g., sugary snacks, juice) to counteract hypoglycemic episodes. Alcohol consumption increases hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also a potential consequence. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease necessitates physician consultation before initiating treatment. Pregnant or lactating individuals must consult their doctor. Regular blood glucose monitoring, along with periodic blood tests assessing blood cell counts and liver function, are essential.

Uses of Glimidale M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimidale M 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimidale M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

Common Side effects of Glimidale M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimidale M 1mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimidale M 1mg/500mg Extended-Release tablets should be administered with a meal.

How Glimidale M 1mg/500mg Tablet SR works:

Glimidale M SR tablets (1mg/500mg) combine glimepiride and metformin to manage blood sugar. Glimepiride, a sulfonylurea, stimulates insulin release from the pancreas, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption and Glimidale M 1mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimidale M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against possible risks prior to prescribing this medication. Seek medical advice before taking this drug.

Breast feedingBreast feedingUNSAFE

Extended-release Glimidale M tablets (1mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

For individuals with kidney impairment, the use of Glimidale M 1mg/500mg SR tablets requires careful consideration. Dosage modification may be necessary; physician consultation is advised. In cases of severe kidney disease, Glimidale M 1mg/500mg SR tablets are contraindicated. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimidale M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with mild to moderate hepatic dysfunction, initiation should be at a low dose; however, this medication is contraindicated in those with severe liver disease.

What if you forget to take Glimidale M 1mg/500mg Tablet SR :

Should you forget to take your Glimidale M 1mg/500mg SR tablet, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Glimidale M 1mg/500mg Tablet SR

LabelValue
Addictive None.
Medication Classification Diabetes medication

FAQs on Glimidale M 1mg/500mg Tablet SR

Retain this medication in its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Glimidale M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this infrequent side effect of metformin poses a significant risk to individuals with kidney impairment, the elderly, or those who consume excessive alcohol. Symptoms may include muscular discomfort or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Glimidale M 1mg/500mg Tablet SR and seek immediate medical attention.
Glimepiride and Metformin, combined as Glimidale M 1mg/500mg SR tablets, manage type 2 diabetes mellitus (DM) in adults. This dual-action therapy enhances blood sugar control when coupled with a healthy diet and physical activity. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin concurrently decreases hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for type 1 DM.
Taking Glimidale M 1mg/500mg Tablets SR may result in common side effects such as low blood sugar, taste changes, queasiness, abdominal discomfort, loose stools, and headaches. Rare but potentially serious side effects include lactic acidosis. Prolonged use could also cause a deficiency in Vitamin B12.
Prolonged use of Glimidale M 1mg/500mg SR tablets can indeed lead to Vitamin B12 deficiency. This medication impedes the stomach's absorption of Vitamin B12. Untreated deficiency may result in anemia, neurological issues, such as tingling and numbness in the extremities, muscle weakness, urinary difficulties, cognitive changes, and impaired balance. To mitigate these risks, supplemental Vitamin B12 intake, at least annually, is recommended by some studies.
Glimidale M 1mg/500mg SR tablets can induce hypoglycemia. Low blood sugar symptoms may include nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and anxiety or tremors. The risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carry a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Consuming alcohol while taking Glimidale M 1mg/500mg SR tablets is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimidale M 1mg/500mg Tab...
57
MRP 70
18% off